Clinical Certificate

Drug Treatments in Affective Disorders

Date: September 2019
Venue: The International Centre for Life (Conferences), Newcastle upon Tyne, NE1 4EP
Organised by: TBA

Programme

Programme to be confirmed

Last edited 23rd May 2018

Learning Objectives

  • Natural history and pathophysiology of affective disorders
    • To understand the Natural History of Mood Disorders
    • To be aware of the main theories of the pathophysiology of mood disorders and the
      relationship of these to drugs
  • Pharmacokinetics and mechanism of action of antidepressants
    • To understand the basic pharmacokinetics of antidepressants
    • To understand the relevance of differing pharmacokinetic properties of antidepressants to their clinical usage
    • To understand the presumed mechanism of action of various classes of antidepressant drugs
  • Antidepressants in clinical practice
    • To recognise various stages in the management of patients with antidepressants
    • To understand how various classes of antidepressants may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of antidepressants
  • Management of treatment resistant depression
    • To understand the epidemiology, clinical features and associations of this disorder.
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.
  • Lithium
    • To understand how Lithium may be used clinically
    • To know the details of published guidelines regarding the choice and clinical usage of Lithium
    • To appreciate the neurobiological underpinnings of Lithium’s actions
  • Other treatments for bipolar disorder
    • To be able to construct a rational management plan.
    • To explore the evidence base in this topic and make rational pharmacological treatment plans.
    • To be able to consider what additional investigations or treatments are required.

This module is eligible for 10 CPD hours which are subject to peer group review.

For further details contact Susan Chandler, BAP Executive Officer: susan@bap.org.uk

Feedback from 2017 Module

"Excellent conference – the best of the three that I have attended so far"

"Highly clinically relevant with high quality presentations"

"Great course"

"Excellent course. All useful info which will help me in day to day prescribing."